Seshadri Neervannan

Companies

• Tarsus Pharmaceuticals, Inc.Chief operating officer Oct 15, 2020 to now¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• TPTarsus Pharmaceuticals, Inc. TARS79,007 shares²$5.5M at $69.64Sep 9, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Sep 4, 2026Sold 4,564 shares at $85.00 of Tarsus Pharmaceuticals, Inc.²
• Mar 20, 2026Sold 2,989 shares at $66.75 of Tarsus Pharmaceuticals, Inc.³
• Mar 19, 2026Sold 4,589 shares at $67.00 of Tarsus Pharmaceuticals, Inc.⁴
• Mar 18, 2026Sold 3,610 shares at $68.71 of Tarsus Pharmaceuticals, Inc.⁴
• Mar 17, 2026Sold 3,125 shares at $69.42 of Tarsus Pharmaceuticals, Inc.⁴
• Mar 15, 2026Exercised options 26,287 shares of Tarsus Pharmaceuticals, Inc.⁵
• Mar 4, 2026Sold 8,366 shares at $76.67 of Tarsus Pharmaceuticals, Inc.⁶
• Dec 16, 2025Gift 475 shares of Tarsus Pharmaceuticals, Inc.⁷
• Dec 16, 2025Gift 950 shares of Tarsus Pharmaceuticals, Inc.⁷
• Mar 20, 2025Sold 2,435 shares at $50.11 of Tarsus Pharmaceuticals, Inc.⁸
• Mar 19, 2025Sold 2,543 shares at $47.40 of Tarsus Pharmaceuticals, Inc.⁸
• Mar 18, 2025Sold 2,605 shares at $46.29 of Tarsus Pharmaceuticals, Inc.⁸
• Mar 15, 2025Exercised options 21,264 shares of Tarsus Pharmaceuticals, Inc.⁹
• Mar 18, 2024Sold 4,879 shares at $30.60 of Tarsus Pharmaceuticals, Inc.¹⁰
• Mar 15, 2024Exercised options 13,245 shares of Tarsus Pharmaceuticals, Inc.¹⁰
• Mar 23, 2023Sold 390 shares at $12.15 of Tarsus Pharmaceuticals, Inc.¹¹
• Mar 22, 2023Sold 379 shares at $12.64 of Tarsus Pharmaceuticals, Inc.¹¹
• Mar 21, 2023Sold 372 shares at $12.89 of Tarsus Pharmaceuticals, Inc.¹¹
• Mar 20, 2023Sold 380 shares at $12.61 of Tarsus Pharmaceuticals, Inc.¹²
• Mar 17, 2023Sold 360 shares at $13.28 of Tarsus Pharmaceuticals, Inc.¹²
• Mar 16, 2023Sold 357 shares at $13.43 of Tarsus Pharmaceuticals, Inc.¹³
• Mar 15, 2023Exercised options 5,097 shares of Tarsus Pharmaceuticals, Inc.¹³